Waddell & Associates’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,901
Closed -$202K 464
2025
Q4
$202K Sell
1,901
-504
-21% -$58.4K 0.01% 366
2025
Q3
$305K Buy
+2,405
New +$286K 0.03% 211

Other funds holding EHC

Waddell & Associates's EHC Position: Q1 2026 in Review

Waddell & Associates sold out of Encompass Health (EHC) in Q1 2026, closing a stake of 1,901 shares — an estimated $202K sold.

Waddell & Associates first reported a position in EHC in Q3 2025 and held it in 2 quarters. The position peaked at $305K in Q3 2025. 578 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Waddell & Associates reported no remaining Encompass Health position as of Q1 2026 after selling out during the quarter.
  • Waddell & Associates sold 1,901 Encompass Health shares in Q1 2026, an estimated $202K.
  • Waddell & Associates first reported a position in Encompass Health in Q3 2025 and held it in 2 quarters.
  • Waddell & Associates's Encompass Health position peaked at $305K in Q3 2025.
  • 578 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Waddell & Associates's 13F filing for Q1 2026, filed 11 May 2026.